Verizon Communications, Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Sell

35

VZ
Verizon Communications, Inc.

Last Price:

$40.20

Seasonality Move:

0.9%

Sell

36

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:

$34.67

Seasonality Move:

-0.96%

Sell

35

Verizon Communications, Inc. (VZ) is a Sell

Is Verizon Communications, Inc. a Buy, Sell or Hold?

The current Verizon Communications, Inc. [VZ] share price is $39.92. The Score for VZ is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
VZ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

36

Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $34.13. The Score for RARE is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VZ Stock Price Chart

What is Verizon Communications, Inc.'s stock price today?

The Verizon Communications, Inc. share price today is $39.92

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VZ is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

The Ultragenyx Pharmaceutical, Inc. share price today is $34.13

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

VZ Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	9.89	Buy
Relative Strength Index (14 RSI):	43.05	Sell
Chaikin Money Flow:	-13272833	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(40.19 - 41.21)	Sell
Bollinger Bands (100):	(40.08 - 43.66)	Sell

RARE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	8.37	Buy
Relative Strength Index (14 RSI):	49.06	Sell
Chaikin Money Flow:	-718174	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(32.83 - 36.03)	Sell
Bollinger Bands (100):	(29.35 - 34.29)	Buy

VZ Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	40.43	Sell
20-day SMA:	40.63	Sell
50-day SMA:	40.35	Sell
200-day SMA:	42.54	Sell
8-day EMA:	28.68	Buy
20-day EMA:	15.81	Buy
50-day EMA:	7.28	Buy
200-day EMA:	1.96	Buy

RARE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	34.4	Sell
20-day SMA:	34.92	Sell
50-day SMA:	33.85	Buy
200-day SMA:	33.54	Buy
8-day EMA:	24.23	Buy
20-day EMA:	13.29	Buy
50-day EMA:	6.11	Buy
200-day EMA:	1.64	Buy

Verizon Communications, Inc. Earnings Growth & VZ Earnings Dates

Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.11 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Verizon Communications, Inc. Technical Analysis

	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17	Dec 18	Dec 19	Dec 22	Dec 23
	Dec
	10	11	12	15	16	17	18	19	22	23
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17	Dec 18	Dec 19	Dec 22	Dec 23
	Dec
	10	11	12	15	16	17	18	19	22	23
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):